Results 371 to 380 of about 327,068 (394)

Severe eosinophilic asthma and mepolizumab

The Lancet Respiratory Medicine, 2016
openaire   +3 more sources

Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society

Ca-A Cancer Journal for Clinicians, 2020
Carmen E Guerra, Kevin C Oeffinger, Louise C Walter   +2 more
exaly  

Real-World Effectiveness and the Characteristics of a 'Super-Responder' to Mepolizumab in Severe Eosinophilic Asthma.

Chest, 2020
J. Kavanagh, G. D'ancona, Maria Elstad, L. Green, M. Fernandes, L. Thomson, C. Roxas, J. Dhariwal, A. Nanzer, B.D. Kent, David J. Jackson, David J. Jackson   +11 more
semanticscholar   +1 more source

Cardio‐oncology care in the era of the coronavirus disease 2019 (COVID‐19) pandemic: An International Cardio‐Oncology Society (ICOS) statement

Ca-A Cancer Journal for Clinicians, 2020
Joerg Herrmann, Daniel J Lenihan, Joseph Carver   +2 more
exaly  

Lysis of primed eosinophils in severe asthma

Journal of Allergy and Clinical Immunology, 2013
openaire   +3 more sources

Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management

Ca-A Cancer Journal for Clinicians, 2016
Giuseppe Curigliano, Daniela Maria Cardinale, Susan Dent   +2 more
exaly  

Longitudinal analyses reveal immunological misfiring in severe COVID-19

Nature, 2020
Adam J Moore, Saad B Omer, Akiko Iwasaki
exaly  

Benralizumab (Fasenra) for Severe Eosinophilic Asthma

JAMA, 2018
openaire   +2 more sources

Oral complications of cancer and cancer therapy

Ca-A Cancer Journal for Clinicians, 2012
Joel B Epstein, Juliette Thariat, René Jean Bensadoun   +2 more
exaly  

Hypercalcemia and cancer: Differential diagnosis and treatment

Ca-A Cancer Journal for Clinicians, 2018
Sarah B Fisher, Nancy D Perrier
exaly